https://doi.org/10.4081/cc.2024.15776
Kinetic oscillation stimulation for the preventive treatment of refractory chronic migraine: a case series
Accepted: 18 December 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Background: Refractory migraine refers to a subtype of chronic migraine in which individuals experience severe and disabling attacks that do not respond adequately to any pharmacological treatment. In recent years, neuromodulation techniques have emerged as promising therapeutic avenues for refractory migraine management.
Methods: Four patients with refractory chronic migraine were offered a six-week cycle of kinetic oscillation stimulation (KOS), a novel approach of neuromodulation whose target is the sphenopalatine ganglion (SPG). Migraine frequency and medication usage were recorded in a diary; intensity of pain and impact of migraine on patient’s behavior were assessed with validated clinical scales.
Results: All except one patient completed the scheduled sessions. Severity of pain and drug consumption remained stable in most cases. After one month of active stimulation, migraine frequency did not differ substantially from pre-operative monthly average, except in one subject who recorded a reduction of 11 monthly migraine days (MMD). A second treatment cycle was proposed for this patient, considering the excellent clinical outcome.
Conclusions: KOS could be a helpful resource and drug-sparing option for selected patients with refractory migraine. However, more evidence is needed to confirm its efficacy and establish a shared usage protocol.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Most read articles by the same author(s)
- Marilena Marcosano, Nicoletta Brunelli, Alessandro Alesina, Luisa Fofi, Claudia Altamura, Fabrizio Vernieri, Diaphragmatic small bowel disease in a patient with resistant migraine and medication overuse treated with galcanezumab , Confinia Cephalalgica: Vol. 34 No. 2 (2024)
Similar Articles
- Editorial office, Expert consensus document on criteria for assessing disability and invalidity in chronic primary headache. From the law to the implementation of diagnostic-therapeutic pathways , Confinia Cephalalgica: Vol. 33 No. 1 (2023)
You may also start an advanced similarity search for this article.
